Lexaria Bioscience Corp (LEXX)
3.15
+0.01
(+0.32%)
USD |
NASDAQ |
May 17, 16:00
2.99
-0.16
(-5.08%)
After-Hours: 20:00
Lexaria Bioscience Cash from Investing (Quarterly): -0.057M for Feb. 29, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -0.057M |
| November 30, 2023 | -0.04M |
| August 31, 2023 | -0.0684M |
| May 31, 2023 | -0.0336M |
| February 28, 2023 | -0.0327M |
| November 30, 2022 | -0.0348M |
| August 31, 2022 | -0.05M |
| May 31, 2022 | -0.038M |
| February 28, 2022 | -0.0344M |
| November 30, 2021 | -0.0582M |
| August 31, 2021 | -0.00 |
| May 31, 2021 | -0.0707M |
| February 28, 2021 | 0.2704M |
| November 30, 2020 | -0.0058M |
| August 31, 2020 | -0.0136M |
| May 31, 2020 | -0.0075M |
| February 29, 2020 | -0.00 |
| November 30, 2019 | -0.0057M |
| August 31, 2019 | -0.0331M |
| May 31, 2019 | -1.239M |
| February 28, 2019 | 0.6703M |
| November 30, 2018 | -0.1672M |
| August 31, 2018 | -0.0268M |
| May 31, 2018 | -0.0266M |
| February 28, 2018 | -0.0163M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.0857M |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.004M |
| November 30, 2016 | -0.0137M |
| August 31, 2016 | -0.0047M |
| May 31, 2016 | -0.0003M |
| February 29, 2016 | -0.012M |
| November 30, 2015 | -0.0031M |
| August 31, 2015 | 0.004M |
| May 31, 2015 | -0.041M |
| February 28, 2015 | 0.7218M |
| November 30, 2014 | 0.00 |
| July 31, 2014 | -0.0516M |
| April 30, 2014 | -0.0314M |
| January 31, 2014 | -0.025M |
| October 31, 2013 | -0.0062M |
| July 31, 2013 | -0.0001M |
| April 30, 2013 | -0.0271M |
| January 31, 2013 | -0.0371M |
| October 31, 2012 | -0.027M |
| July 31, 2012 | -0.2019M |
| April 30, 2012 | 0.00 |
| January 31, 2012 | -0.0452M |
| October 31, 2011 | -0.7215M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.239M
Minimum
May 2019
0.2704M
Maximum
Feb 2021
-0.0776M
Average
-0.034M
Median
Cash from Investing (Quarterly) Benchmarks
| Sunshine Biopharma Inc | -0.2692M |
| Acasti Pharma Inc | -6.554M |
| Aurinia Pharmaceuticals Inc | -6.257M |
| Edesa Biotech Inc | -- |
| Xenon Pharmaceuticals Inc | -46.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.6196M |
| Cash from Financing (Quarterly) | 3.453M |
| Free Cash Flow | -5.408M |
| Free Cash Flow Per Share (Quarterly) | -0.0629 |
| Free Cash Flow to Equity (Quarterly) | -0.6766M |
| Free Cash Flow Yield | -19.98% |